Walden Biosciences
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of WAL0921 in Patients With Glomerular Kidney Diseases (NCT06466135) | Walden Biosciences | 2024-07-02 |
| Single Ascending Dose Study of WAL0921 in Healthy Subjects (NCT05891366) | Walden Biosciences | 2023-05-31 |
Track Walden Biosciences automatically
Every clearance here is in the API, with alerts when new ones post.